Effect of GF120918, a Potent P-glycoprotein Inhibitor, on Morphine Pharmacokinetics and Pharmacodynamics in the Rat

[1]  G. Pollack,et al.  Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception. , 1997, Biochemical pharmacology.

[2]  Liyue Huang,et al.  MDR1 Substrates/Modulators Protect against β-Estradiol-17β-d-Glucuronide Cholestasis in Rat Liver , 1996 .

[3]  J. Drewe,et al.  Evidence for P‐glycoprotein‐modulated penetration of morphine‐6‐glucuronide into brain capillary endothelium , 1996, British journal of pharmacology.

[4]  A. Somogyi,et al.  The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. , 1996, Drug metabolism reviews.

[5]  P. Borst,et al.  Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.

[6]  R T Borchardt,et al.  The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. , 1995, The Journal of pharmacology and experimental therapeutics.

[7]  G. Pollack,et al.  Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[8]  I. Tamai,et al.  In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. , 1994, Biochemical pharmacology.

[9]  M. Vore,et al.  17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter. , 1993, Cancer research.

[10]  E. Kalso,et al.  Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats. , 1993, European journal of pharmacology.

[11]  C. Vergely,et al.  In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. , 1993, Cancer research.

[12]  J. Riordan,et al.  Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. , 1993, The Journal of biological chemistry.

[13]  A. Dickenson,et al.  Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study , 1993, Pain.

[14]  T. Tsuruo,et al.  [Functional involvement of P-glycoprotein in blood-brain barrier]. , 1992, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[15]  I. Pastan,et al.  Multidrug resistance in human cancer. , 1992, Critical reviews in oncology/hematology.

[16]  G. Pollack,et al.  Enterohepatic recirculation and renal metabolism of morphine in the rat. , 1991, Journal of pharmaceutical sciences.

[17]  P. Glare,et al.  A Simple, Rapid Method for the Simultaneous Determination of Morphine and Its Principal Metabolites in Plasma Using High‐Performance Liquid Chromatography and Fluorometric Detection , 1991, Therapeutic drug monitoring.

[18]  M. Melamed,et al.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  H L Pearce,et al.  Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H L Pearce,et al.  Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. , 1988, Molecular pharmacology.

[21]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Lewis B. Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .

[23]  W. S. Koski,et al.  Microelectrometric titration measurement of the pKa's and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence. , 1975, Journal of medicinal chemistry.

[24]  T. L. Lloyd,et al.  Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  T. Reisine.  Opioid analgesics and antagonists , 1996 .

[26]  T. Tsuruo,et al.  P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. , 1992, Life sciences.

[27]  R. Venn,et al.  Fast reliable assay for morphine and its metabolites using high-performance liquid chromatography and native fluorescence detection. , 1990, Journal of chromatography.